HONG KONG -- Chinese medical technology startup SiBionics has raised nearly 500 million yuan ($72 million) in a Series D round of financing to expand its development of artificial intelligence-based devices for chronic disease management.
Shenzhen-based SiBionics this week announced it had secured the new financing from lead investors Shanghai Biomedical Industrial Equity Investment Fund and Guangdong Chinese Medicine and Mass Health Fund.
